Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 6-MTH group results

Oct 29 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              145.90              132.21           289.50    
                   (+10.4 pct)         (+2.1 pct)       (+0.3 pct)  
  Operating           16.30               14.53            20.00    
                   (+12.2 pct)         (-14.5 pct)      (-5.4 pct)  
  Recurring           18.86               14.61            23.00    
                   (+29.1 pct)         (-35.7 pct)      (-6.0 pct)  
  Net                 11.29               14.78            13.00    
                   (-23.6 pct)         (-65.2 pct)      (-35.6 pct) 
  EPS              141.51 yen          185.23 yen       162.89 yen  
  EPS Diluted      141.34 yen          185.02 yen                   
  Ann Div                              110.00 yen       100.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               60.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news